A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants

Clinical trial NCT02219256 · COMPLETED

Trial details

NCT number: NCT02219256
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Disease

Start date: 2014-08-01
Primary completion: 2016-04-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.